• Amrita Soni Sagar Institute of Pharmaceutical Sciences (SIPS), NH-26, Narsinghpur Road, Sironja, Sagar
  • Vaibhav Rajoriya Sagar Institute of Pharmaceutical Sciences (SIPS), NH-26, Narsinghpur Road, Sironja, Sagar
  • Varsha Kashaw Sagar Institute of Phramaceutical sciences, Sironja, Sagar, (M.P.), 470228


Objective: The aim of this study was to prepare fast dissolving tablet of Ramipril by using Sodium starch glycolate, and Crospovidone as superdisintegrants to enhance the dissolution rate and the disintegration rate and evaluated for Pre and Post Compression parameter of the tablet.

Methods: Fast dissolving tablet of Ramipril was prepared by direct compression technique. Fast dissolving tablet was evaluated for Pre compression parameter; bulk density, tapped density, Hausner's ratio, angle of repose and Carr's index and post compression parameter; weight variation, thickness, hardness, friability, wetting time, water absorption ratio, disintegration time and dissolution time. The UV-spectrophotometric method has been used for the quantitation of drug release of Ramipril in the Fast dissolving tablet formulation.

Results: Pre and post compression parameter were evaluated. Five different batches of tablets, F1 to F5 were prepared. Bulk density and tapped density was found in the range of 0.64-0.85 g/cm3 and 0.68-0.98 g/cm3 simultaneously. The hardness, friability, wetting time, the water absorption ratio, disintegration and dissolution time were found to be acceptable according to the standard limit and compare to all formulations F4 formulation was selected as the promising formulation. All batches of fast dissolving tablet were satisfactory in term of dissolution. The cumulative percentage of drug release of F4 formulation was 90.12% after 12 min compare to other formulation.

Conclusion: The result suggested that the dissolution and disintegration of Ramipril have improved considerably in batch F4 formulation as compared to rest of the formulation. The dissolution rate and dissolution rate of Ramipril can be enhanced to a great extent by the direct compression technique with the addition of superdisintegrants.

Keywords: Fast dissolving tablet, Ramipril, Sodium starch glycolate, Crospovidone


Download data is not yet available.


1. Suresh B, Rajender KM, Ramesh G, Yamsani MR. Orodispersible tablets: An overview. Asian J Pharm 2008;2:2-11.
2. Seager H. Drug delivery product and zydis-fast dissolving dosage form. J Pharm Pharmacol 1998;50:375-82.
3. Abdelbary G, Prinderre P, Couani C, Taochim J, Reynier JP, Riccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm 2004;278(2):423-33.
4. Sastry SV, Nyshadham JR, Fix JA. Recent technological advances in oral drug delivery: a review. Pharm Sci Techol Today 2000;3(4):138-45.
5. Lachman L, Libermann HA, Kanig JL. The theory and practice of industrial pharmacy. 3rd edition; 1991. p. 233-5.
6. Biradar S, Bhagavati S, Kuppasad I. Fast dissolving drug delivery system: A brief overview. Internet J Pharmacol 2005;4:2.
7. Indurwade NH, Rajyaguru TH, Nakhat PD. Noval approach-fast dissolving tablets. Indian Drug 2002;38(8):405-9.
8. Chang RK, Guo X, Burnside BA, Couch RA. Fast dissolving tablets. Pharm Tech 2000;24:52-8.
9. Fisher ND, Williams GH. Hypertensive vascular disease. In: Kasper DL, Braunwald E, Fauci AS. Harrison's Principles of Internal medicines. 16th edition. New York, NY: McGraw-Hill; 2005. p. 1463–81.
10. Tripathi KD. Essential of Medical Pharmacology. 6th edition. 2008. p. 540-2.
11. Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension 2004;43(5):993-1002.
12. Frampton JE, Peters DH. Ramipril. An updated review of its therapeutic use in essential hypertension and heart failure. Drugs 1995:49(3):440–66.
13. Arnold JM, Yusuf S, Young J, Mathew J, Johnstone D, Avezum A, et al. Prevention of heart failure in patients in the heart outcomes prevention evaluation (HOPE) study. Circulation 2003;107:1284–90.
14. Mehta M, Bhagwat DP, Gupta GD. Fast dissolving tablets of Sertraline HCl. Int J ChemTech Res 2009;1(4):925-30.
15. Gohel MC. A Review of Co-processed directly compressible excipients. J Pharm Pharm Sci 2005;8(1):76-93.
16. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS Pharm Sci Tech 2007;8(1):E1-E6.
17. The United States Pharmacopoeia 29, National Formulary 24, Asian Edition. Rockville, MD: United States Pharmacopoeia Convention, Inc; 2006. p. 1890.
18. Jacob S, Shirwaikar A, Joseph A, Srinivasan KK. Novel co-processed excipient of mannitol and microcrystalline callous for preparing fast dissolving tablet of Glipizide. Indian J Pharm Sci 2007:69(5):633-9.
19. Jha SK, Vijayalakshmi P, Karki R, Goli D. Formulation and evaluation of melt-in-mouth tablets of haloperidol. Asian J Pharm 2008;2(4):255-60.
20. Hiremath JG, Shastry CS, Srinath MS. Pharmaceutical approaches of taste masking in oral dorage forms. Indian Drugs 2004;41:253-7.
726 Views | 2683 Downloads
How to Cite
Soni, A., V. Rajoriya, and V. Kashaw. “FORMULATION DEVELOPMENT AND EVALUATION OF FAST DISSOLVING TABLET OF RAMIPRIL”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 8, June 2015, pp. 127-31,
Original Article(s)